We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Approval Drop. In this article, we ...
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
Mexico, China and Canada were the largest importers for the US in 2023, and the first targets of US President Donald Trump’s ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
This can be found among the Granolas, a group of 11 European multinationals, selected by US bank Goldman Sachs, which is made ...
Novo Nordisk A/S is prepared for potential tariffs ... Trump has threatened tariffs on key trading partners Canada, Mexico and China, which has left some manufacturing companies scrambling to ...
European shares ended Wednesday's choppy session higher, as a rise in healthcare companies GSK and Novo Nordisk following ...
Novo Nordisk A/S is prepared for potential tariffs from US President Donald Trump, the Danish drugmaker’s chief executive said, as tensions simmer between Copenhagen and Washington. Trump has ...
In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... of the White House imposing tariffs on imports from Mexico, Canada, and China. As expected, the tariffs were ...
After steel and aluminium, US President Donald Trump has set his sights on slapping 25 percent tariffs on semiconductors, ...
Novo Nordisk rose after the Danish drugmaker said sales will likely ... Still, President Donald Trump’s decision to delay broad tariffs on Mexico and Canada this week has bolstered confidence in the ...